RMD
Resmed
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: RMD
- PE Ratio
The PE ratio for Resmed stock stands at 18.12 as of Jun 22, 2026. This is calculated based on the TTM EPS of $10.4 and the stock price of $188.45 per share. A decrease of 28% has been observed in the PE ratio compared to its average of 25.1 of the last four quarters.
RMD PE ratio history
Over the last ten years, the average PE ratio of Resmed has been 38.66. The current 18.12 P/E ratio is 53% lower than the historical average. Looking back at the last ten years, RMD's PE ratio peaked in the Sep 2021 quarter at 76.39, with a price of $263.55 and an EPS of $3.45. The Mar 2026 quarter marked the lowest point at 21.58, with a price of $224.48 and an EPS of $10.4.
Resmed PE ratio by year
Maximum annual increase: 69.23% in 2021
Maximum annual decrease: -47.92% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 27.02 | -2.03% | $258 | $9.55 |
| 2024 | 27.58 | -22.75% | $191.42 | $6.94 |
| 2023 | 35.7 | -9.07% | $218.5 | $6.12 |
| 2022 | 39.26 | -47.92% | $209.63 | $5.34 |
| 2021 | 75.39 | 69.23% | $246.52 | $3.27 |
| 2020 | 44.55 | 3.32% | $192 | $4.31 |
| 2019 | 43.12 | -8% | $122.03 | $2.83 |
| 2018 | 46.87 | 45.65% | $103.58 | $2.21 |
| 2017 | 32.18 | 27.75% | $77.87 | $2.42 |
| 2016 | 25.19 | 12.15% | $63.23 | $2.51 |
| 2015 | 22.46 | 8.24% | $56.37 | $2.51 |
| 2014 | 20.75 | -1.14% | $50.63 | $2.44 |
| 2013 | 20.99 | 17.72% | $45.13 | $2.15 |
| 2012 | 17.83 | -14.16% | $31.2 | $1.75 |
| 2011 | 20.77 | -13.92% | $30.95 | $1.49 |
Resmed PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 21.58 | -9.06% | $224.48 | $10.4 |
| Dec 2025 | 23.73 | -14.95% | $240.87 | $10.15 |
| Sep 2025 | 27.9 | 3.26% | $273.73 | $9.81 |
| Jun 2025 | 27.02 | 7.91% | $258 | $9.55 |
| Mar 2025 | 25.04 | -7.05% | $223.85 | $8.94 |
| Dec 2024 | 26.94 | -16.57% | $228.69 | $8.49 |
| Sep 2024 | 32.29 | 17.08% | $244.12 | $7.56 |
| Jun 2024 | 27.58 | -9.19% | $191.42 | $6.94 |
| Mar 2024 | 30.37 | 6.97% | $198.03 | $6.52 |
| Dec 2023 | 28.39 | 18.44% | $172.02 | $6.06 |
| Sep 2023 | 23.97 | -32.86% | $147.87 | $6.17 |
| Jun 2023 | 35.7 | -3.98% | $218.5 | $6.12 |
| Mar 2023 | 37.18 | -1.22% | $218.99 | $5.89 |
| Dec 2022 | 37.64 | -7.24% | $208.13 | $5.53 |
| Sep 2022 | 40.58 | 3.36% | $218.3 | $5.38 |
RMD Price vs fair value
RMD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, RMD's PE ratio is lower than its 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 18.12, RMD ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 24.1, Resmed's price to earnings (P/E) is 25% lower.
RMD PE vs peers
RMD's PE ratio stands lower than its peer stocks TMO and MDT.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RMD Resmed Inc | 18.4 | $27.76B |
| MDT Medtronic plc | 21.5 | $103.21B |
| TMO Thermo Fisher Scientific Inc | 25.75 | $174.35B |
| ELMD Electromed Inc | 31.65 | $319.69M |
| INGN Inogen Inc | N/A | $177.34M |
Frequently asked questions
What is Resmed's PE ratio?
RMD's price to earnings ratio is 18.12 as of Jun 22, 2026.
What is the 3-year average PE ratio for Resmed (RMD)?
As an average over the last 3 years, RMD stock has a PE ratio of 27.54.
What is the 5-year average PE ratio for Resmed (RMD)?
As an average over the last 5 years, RMD stock has a PE ratio of 37.74.
What is the highest PE ratio for RMD?
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 76.39.
How does the current PE ratio for RMD compare to its historical average?
The current PE ratio of RMD is 53% lower than the 10-year historical average.
How is RMD's PE ratio calculated (Resmed PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 22, 2026), Resmed's share price is $188.45. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $10.4. Therefore, Resmed's PE ratio for today is 18.12. PE RATIO(18.12) = STOCK PRICE($188.45) / TTM EPS($10.4)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.